AAAAAA
Results:
1-15
|
Results: 15
Authors:
Hanna, JS
Kroll, ES
Lundblad, V
Spencer, FA
Citation: Js. Hanna et al., Saccharomyces cerevisiae CTF18 and CTF4 are required for sister chromatid cohesion, MOL CELL B, 21(9), 2001, pp. 3144-3158
Authors:
Becker, RC
Burns, M
Every, N
Maynard, C
Frederick, P
Spencer, FA
Gore, JM
Lambrew, C
Citation: Rc. Becker et al., Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction - A nationwide perspective, ARCH IN MED, 161(4), 2001, pp. 601-607
Authors:
Spencer, FA
Goldberg, RJ
Frederick, PD
Malmgren, J
Becker, RC
Gore, JM
Citation: Fa. Spencer et al., Age and the utilization of cardiac catheterization following uncomplicatedfirst acute myocardial infarction treated with thrombolytic therapy (The second national registry of myocardial infarction [NRMI-2]), AM J CARD, 88(2), 2001, pp. 107-111
Authors:
Li, YF
Spencer, FA
Becker, RC
Citation: Yf. Li et al., Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alpha IIb/beta(3)) receptor-directed platelet inhibition, AM HEART J, 142(2), 2001, pp. 204-210
Authors:
Spencer, FA
Ball, SP
Zhang, QL
Liu, LB
Benoit, S
Becker, RC
Citation: Fa. Spencer et al., Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization, J THROMB TH, 9(3), 2000, pp. 223-228
Authors:
Spencer, FA
Citation: Fa. Spencer, Key references : Protein C, protein S, and antithrombin III deficiencies, J THROMB TH, 9(1), 2000, pp. 127-127
Authors:
Spencer, FA
Citation: Fa. Spencer, Key references: Antiphospholipid antibody syndrome, J THROMB TH, 9(1), 2000, pp. 129-130
Authors:
Li, YF
Spencer, FA
Ball, S
Becker, RC
Citation: Yf. Li et al., Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: Potential contributing mechanism of benefit in acute coronary syndromes, J THROMB TH, 10(1), 2000, pp. 69-76
Authors:
Spencer, FA
Citation: Fa. Spencer, Heparin-induced thrombocytopenia: Patient profiles and clinical manifestations, J THROMB TH, 10, 2000, pp. S21-S25
Authors:
Becker, RC
Spencer, FA
Citation: Rc. Becker et Fa. Spencer, Hematological evaluation of stroke risk, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 51-77
Authors:
Green, ED
Hieter, P
Spencer, FA
Citation: Ed. Green et al., Yeast artificial chromosomes, GENOME ANAL, 3, 1999, pp. 297-565
Authors:
Spencer, FA
Becker, RC
Citation: Fa. Spencer et Rc. Becker, Diagnosis and management of inherited and acquired thrombophilias, J THROMB TH, 7(2), 1999, pp. 91-104
Authors:
Spencer, FA
Meyer, TE
Goldberg, RJ
Yarzebski, J
Hatton, M
Lessard, D
Gore, JM
Citation: Fa. Spencer et al., Twenty year trends (1975-1995) in the incidence, in-hospital and long-termdeath rates associated with heart failure complicating acute myocardial infarction - A community-wide perspective, J AM COL C, 34(5), 1999, pp. 1378-1387
Authors:
Becker, RC
Spencer, FA
Li, YF
Ball, SP
Ma, YS
Hurley, T
Hebert, J
Citation: Rc. Becker et al., Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes - Potential mechanisms for heightened prothrombotic potential, J AM COL C, 34(4), 1999, pp. 1020-1027
Authors:
Becker, RC
Hochman, JS
Cannon, CP
Spencer, FA
Ball, SP
Rizzo, MJ
Antman, EM
Citation: Rc. Becker et al., Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists - Observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study, J AM COL C, 33(2), 1999, pp. 479-487
Risultati:
1-15
|